Kobayashi T, Yokoyama I, Morozumi K, Nagasaka T, Hayashi S, Uchida K, Takagi H, Nakao A
Department of Surgery II, Nagoya University School of Medicine, Japan.
Xenotransplantation. 2000 May;7(2):101-8. doi: 10.1034/j.1399-3089.2000.00063.x.
Successful clinical ABO-incompatible renal transplantation has been achieved by the removal of anti-A or anti-B antibodies using double filtration plasmapheresis (DFPP). We have compared changes in the levels of anti-donor antibodies and the histopathology of the renal grafts following human ABO-incompatible allotransplantation and pig-to-baboon xenotransplantation using pretransplant DFPP. DFPP was performed on days 6, -4, -2 and -1 before the ABO-incompatible transplants (n=25) and on days -2 and 0 (immediately before reperfusion) in the xenotransplants (n=4). In two baboons (XenoTx Group I) the extent of antibody removal was comparable to that in the ABO-incompatible patients, and an even greater level of removal was achieved in another two baboons (XenoTx Group II). Anti-A and anti-B and anti-pig IgM and IgG antibodies were measured by flow cytometry. All clinical ABO-incompatible renal grafts are functioning, except two which were lost from recurrence of the original disease or from chronic rejection. Three other grafts underwent humoral rejection episodes, which were successfully treated. DFPP reduced the mean anti-A/B IgM and IgG antibody levels to 8% and 13% of pretreatment levels, respectively. After kidney transplantation, they were maintained at 37% and 46% of pre-DFPP level. No antibody binding to the transplanted kidney was detected at any time (1 h to 2 yr) after ABO-incompatible allotransplantation. In contrast, in XenoTx Group I, the same extent of antibody removal (90%) prevented hyperacute rejection, but the two grafts were rejected on days 6 and 7, respectively, from acute vascular rejection. In XenoTx Group II, the additional DFPP that was required to deplete the remaining 10% of anti-pig antibody was poorly tolerated and the two baboons died 4 h and 2 days, respectively, after renal transplantation. Although anti-pig IgM antibodies were reduced to 2% of pre-treatment level, IgM and C3 binding were detected in the graft as early as 1 h posttransplantation. These data suggest that the concentration of xeno-antigen epitopes expressed on pig organs may need to be reduced by genetic engineering to the much lower level of blood group A/B antigens on human kidneys if discordant xenotransplantation is to be successful.
通过使用双重滤过血浆置换术(DFPP)去除抗A或抗B抗体,已成功实现临床ABO血型不相容肾移植。我们比较了使用移植前DFPP进行人类ABO血型不相容同种异体移植和猪到狒狒异种移植后抗供体抗体水平的变化以及肾移植的组织病理学情况。在ABO血型不相容移植前的第6天、-4天、-2天和-1天(n = 25)以及异种移植的第-2天和0天(再灌注前即刻)(n = 4)进行DFPP。在两只狒狒(异种移植I组)中,抗体清除程度与ABO血型不相容患者相当,另外两只狒狒(异种移植II组)实现了更高水平的清除。通过流式细胞术检测抗A、抗B以及抗猪IgM和IgG抗体。所有临床ABO血型不相容肾移植均在发挥功能,除了两例因原发病复发或慢性排斥而丢失。另外三例移植发生了体液排斥反应,经成功治疗。DFPP分别将抗A/B IgM和IgG抗体的平均水平降至预处理水平的8%和13%。肾移植后,它们维持在DFPP前水平的37%和46%。在ABO血型不相容同种异体移植后的任何时间(1小时至2年)均未检测到抗体与移植肾结合。相比之下,在异种移植I组中,相同程度的抗体清除(90%)预防了超急性排斥,但两个移植物分别在第6天和第7天因急性血管排斥而被排斥。在异种移植II组中,为耗尽剩余10%的抗猪抗体所需的额外DFPP耐受性差,两只狒狒分别在肾移植后4小时和2天死亡。尽管抗猪IgM抗体降至预处理水平的2%,但早在移植后1小时就在移植物中检测到IgM和C3结合。这些数据表明,如果不协调性异种移植要取得成功,可能需要通过基因工程将猪器官上表达的异种抗原表位浓度降低至人类肾脏上血型A/B抗原的低得多的水平。